Cargando…

Randomized Trial of Tocilizumab in the Treatment of Refractory Adult Polymyositis and Dermatomyositis

OBJECTIVE: To assess the efficacy and tolerability of tocilizumab in a multicenter, randomized, double‐blind, placebo‐controlled trial in refractory adult patients with dermatomyositis (DM) and polymyositis (PM). METHODS: Thirty‐six subjects with probable or definite DM/PM were enrolled in a 6‐month...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oddis, Chester V., Rockette, Howard E., Zhu, Lei, Koontz, Diane C., Lacomis, David, Venturupalli, Swamy, Moghadam‐Kia, Siamak, Ascherman, Dana P., Crofford, Leslie, Dimachkie, Mazen M., Ernste, Floranne, Gazeley, David, Marder, Galina, Aggarwal, Rohit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Periodicals, Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661830/ https://www.ncbi.nlm.nih.gov/pubmed/36128663 http://dx.doi.org/10.1002/acr2.11493

Ejemplares similares

Nutrition and Polymyositis and Dermatomyositis
por: Loell, Ingela, et al.
Publicado: (2008)

Predictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprine
por: Schiopu, Elena, et al.
Publicado: (2012)

Viral Etiology of Polymyositis/Dermatomyositis
por: DENMAN, A.M.
Publicado: (1988)

Subcutaneous Edema in Polymyositis and Dermatomyositis
por: Yoshimi, Ryusuke, et al.
Publicado: (2023)

Polymyositis and dermatomyositis: Disease spectrum and classification
por: Raychaudhuri, Siba P, et al.
Publicado: (2012)

Polymyositis and dermatomyositis – challenges in diagnosis and management
por: Yang, Shu-Han, et al.
Publicado: (2019)

Dermatomyositis and polymyositis in total hip arthroplasty
por: Rosas, Samuel, et al.
Publicado: (2021)

Polymyositis and dermatomyositis as a risk of developing cancer
por: Jakubaszek, Michał, et al.
Publicado: (2015)

Cardiac involvement in polymyositis and dermatomyositis: diagnostic approaches
por: Trybuch, Agnieszka, et al.
Publicado: (2023)

Circulating plasma microRNA profiling in patients with polymyositis/dermatomyositis before and after treatment: miRNA may be associated with polymyositis/dermatomyositis
por: Hirai, Takuya, et al.
Publicado: (2018)

Potential role of autophagy in T-cell survival in polymyositis and dermatomyositis
por: Shu, Xiaoming, et al.
Publicado: (2017)

Hyaluronic acid in dermatomyositis and polymyositis: relationship with disease and cutaneous lesions
por: Silva, Marilda Guimarães, et al.
Publicado: (2018)

STROBE: The correlation of Cyr61, CTGF, and VEGF with polymyositis/dermatomyositis
por: Chai, Ke-Xia, et al.
Publicado: (2018)

Identification of hub biomarkers and immune cell infiltration in polymyositis and dermatomyositis
por: Chen, Si, et al.
Publicado: (2022)

Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan
por: Chen, Yi-Ju, et al.
Publicado: (2010)

Expression of TLR2, TLR4, and TLR9 in dermatomyositis and polymyositis
por: Kim, Geun-Tae, et al.
Publicado: (2009)

The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease
por: Sugiyama, Yumiko, et al.
Publicado: (2018)

Upregulation of Interleukin 21 and Interleukin 21 Receptor in Patients with Dermatomyositis and Polymyositis
por: Liu, Tao, et al.
Publicado: (2017)

Epilepsy as a Comorbidity in Polymyositis and Dermatomyositis—A Cross-Sectional Study
por: Nissan, Ella, et al.
Publicado: (2021)

Supervised Physical Therapy and Polymyositis/Dermatomyositis—A Systematic Review of the Literature
por: Corrado, Bruno, et al.
Publicado: (2020)

Clinical Features of Dermatomyositis/Polymyositis with Anti-MDA5 Antibody Positivity
por: Chen, Qiuhe, et al.
Publicado: (2022)

Clinical and Radiological Features of Interstitial Lung Diseases Associated with Polymyositis and Dermatomyositis
por: Palmucci, Stefano, et al.
Publicado: (2022)

Serum uric acid is independently associated with hypertension in patients with polymyositis and dermatomyositis
por: liu, mei, et al.
Publicado: (2023)

HMGB1, a new proinflammatory molecule of interest in polymyositis and dermatomyositis patients
por: Grundtman, C, et al.
Publicado: (2003)

Coadministration of Cyclosporin A with Prednisolone in Acute Interstitial Pneumonia Complicating Polymyositis/Dermatomyositis
por: Shimojima, Yasuhiro, et al.
Publicado: (2012)

Chloroquine diphosphate: a risk factor for herpes zoster in patients with dermatomyositis/polymyositis
por: da Cunha, Gilmara Franco, et al.
Publicado: (2013)

Thrombotic Microangiopathy with Polymyositis/Dermatomyositis: Three Case Reports and a Literature Review
por: Yamada, Saeko, et al.
Publicado: (2018)

Increased risk of venous thromboembolism associated with polymyositis and dermatomyositis: a meta-analysis
por: Li, Yanqing, et al.
Publicado: (2018)

Clinical significance of myositis-specific autoantibody profiles in Japanese patients with polymyositis/dermatomyositis
por: Temmoku, Jumpei, et al.
Publicado: (2019)

Meta-Analysis of Polymyositis and Dermatomyositis Microarray Data Reveals Novel Genetic Biomarkers
por: Song, Jaeseung, et al.
Publicado: (2019)

Dermatomyositis and/or polymyositis as a paraneoplastic manifestation of ovarian cancer: a systematic review
por: Psomiadou, Victoria, et al.
Publicado: (2021)

Clinical Features of Anti-Synthetase Syndrome Associated with Prognosis in Patients with Dermatomyositis and Polymyositis
por: Ahn, Sung Soo, et al.
Publicado: (2022)

Inflammatory Bowel Diseases Are Associated with Polymyositis and Dermatomyositis—A Retrospective Cohort Analysis
por: Sharif, Kassem, et al.
Publicado: (2022)

Incidence and impact of interstitial lung disease and malignancy in patients with polymyositis, dermatomyositis, and clinically amyopathic dermatomyositis: a retrospective cohort study
por: Ikeda, Satoshi, et al.
Publicado: (2015)

Laboratory Test Abnormalities are Common in Polymyositis and Dermatomyositis and Differ Among Clinical and Demographic Groups
por: Volochayev, Rita, et al.
Publicado: (2012)

Patient Preference Assessment Reveals Disease Aspects Not Covered by Recommended Outcomes in Polymyositis and Dermatomyositis
por: Alemo Munters, Li, et al.
Publicado: (2011)

Treating refractory dermatomyositis or polymyositis with adrenocorticotropic hormone gel: a retrospective case series
por: Levine, Todd
Publicado: (2012)

Clinical values of FDG PET in polymyositis and dermatomyositis syndromes: imaging of skeletal muscle inflammation
por: Tateyama, Maki, et al.
Publicado: (2015)

T-cell transcriptomics from peripheral blood highlights differences between polymyositis and dermatomyositis patients
por: Houtman, Miranda, et al.
Publicado: (2018)

Targeted lipidomics analysis identified altered serum lipid profiles in patients with polymyositis and dermatomyositis
por: Raouf, Joan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6cctnr6udirg3b4vi42a4tme2h